サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1587505

高分子バイオ分析検査サービス市場規模、シェア、動向分析レポート：フェーズ別、検査別、タイプ別、治療領域別、最終用途別、地域別、セグメント別予測、2025年～2030年

Large Molecule Bioanalytical Testing Services Market Size, Share & Trends Analysis Report By Phase (Preclinical, Clinical), By Test (ADME, PD), By Type, By Therapeutic Area, By End Use, By Region, And Segment Forecasts, 2025 - 2030

出版日
ページ情報
英文 120 Pages
納期
2～10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.57円
高分子バイオ分析検査サービス市場規模、シェア、動向分析レポート：フェーズ別、検査別、タイプ別、治療領域別、最終用途別、地域別、セグメント別予測、2025年～2030年
出版日: 2024年10月16日
発行: Grand View Research
ページ情報: 英文 120 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

高分子バイオ分析検査サービス市場の成長と動向

Grand View Research, Inc.の最新レポートによると、世界の高分子バイオ分析検査サービス市場規模は、2025～2030年にかけて9.63%のCAGRを記録し、2030年までに37億米ドルに達する見込みです。

バイオマーカー、高分子、その他の物質の臨床検査における生物学的分析検査の利用の増加が、この産業の主要促進要因です。慢性疾患の罹患率の上昇と新興国での臨床検査需要の高まりが市場成長の要因です。例えば、WHOによると、2020年には約1,000万人ががんで死亡します。がんの推定によると、2040年までに3,020万人ががんに罹患する可能性があります。その他、生物製剤の増加、先端技術への高い需要、個別化されたオーファンドラッグ＆医薬品へのニーズなどが、同セグメントの成長を促進すると予測されています。

また、技術の進歩、臨床検査のグローバリゼーション、臨床検査を実施するCROのニーズの高まりなどの要因が産業の拡大を加速すると予測されています。しかし、大手製薬会社やバイオ分析会社は、COVID-19パンデミックの結果、臨床研究や治療に支障をきたし、困難に遭遇しました。臨床検査の開始、前臨床検査、バイオアナリシス、規制当局とのやり取りを含むCOVID-19プロジェクトの作業負荷に加え、他の困難には拠点での労働者の損失が含まれます。COVID以外のイニシアチブは遅れ、COVID検査のための生物学的分析、前臨床、臨床検査をサポートするためにリソースが使われた結果、4-6ヶ月の長い待ち時間が発生しました。また、COVIDに関連するアッセイとそうでないアッセイを解決しなければなりません。

高分子バイオ分析検査サービス市場レポートハイライト

  • 2024年の市場シェアは臨床相が66.6%で最大となっています。慢性疾患の有病率の増加と発展途上国における臨床検査需要の増加が、このセグメントの成長を促進する要因として期待されています。
  • 世界市場は薬剤動態、抗薬剤抗体（ADA）、その他に区分されます。ADAセグメントは、2024年の世界市場で最大の収益シェアを占めました。
  • バイオアベイラビリティセグメントは2024年に最大の収益シェアを占めました。このセグメントの成長は、ジェネリック医薬品製造におけるこれらのサービスに対する高い需要に起因しています。
  • 2024年の世界市場では、がん領域が収益シェアの大半を占めました。また、このセグメントは予測期間中に最も速いCAGRを記録すると予測されています。
  • 市場セグメンテーションは2024年の世界市場を独占しました。同セグメントはまた、予測期間中に最も速いCAGRで成長し、市場の優位性を維持すると予測されています。
  • 北米の高分子バイオ分析検査サービス市場は、2024年に48.94%以上の収益シェアで世界市場を独占しました。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 高分子バイオ分析検査サービス市場の変数、動向、範囲

  • 市場系統の展望
    • 親市場展望
    • 関連/付随市場展望
  • 市場力学
    • 市場促進要因分析
    • 市場抑制要因分析
  • R&D投資と資金調達の観点
  • 臨床検査ボリューム分析（2023年）
  • 価格モデル分析
  • 技術の情勢
  • 高分子バイオ分析検査サービス市場分析ツール
    • ポーターのファイブフォース分析
    • PESTEL分析

第4章 高分子バイオ分析検査サービス市場：フェーズ別、推定・動向分析

  • 高分子バイオ分析検査サービス市場、フェーズ別：セグメントダッシュボード
  • フェーズ別の世界の高分子バイオ分析検査サービス市場：変動分析
  • 相別、2018～2030年（100万米ドル）
  • 前臨床
    • 抗体あり
    • 抗体なし（ELISAベースのアッセイ）
  • 臨床

第5章 高分子バイオ分析検査サービス市場：タイプ別、推定・動向分析

  • 高分子バイオ分析検査サービス市場、タイプ別：セグメントダッシュボード
  • タイプ別の世界の高分子バイオ分析検査サービス市場：変動分析
  • タイプ別、2018～2030年（100万米ドル）
  • 薬剤動態
    • 薬剤動態市場推定・予測、2018～2030年
  • ADA
    • ADA市場推定・予測、2018～2030年
  • その他
    • その他市場推定・予測、2018～2030年

第6章 高分子バイオ分析検査サービス市場：検査タイプ別、推定・動向分析

  • 高分子バイオ分析検査サービス市場、検査タイプ別：セグメントダッシュボード
  • 検査タイプ別の世界の高分子バイオ分析検査サービス市場：変動分析
  • 検査タイプ別、2018～2030年（100万米ドル）
  • ADME
  • PD
  • バイオアベイラビリティ
  • 生物学的同等性
  • その他

第7章 高分子バイオ分析検査サービス市場：治療領域別、推定・動向分析

  • 高分子バイオ分析検査サービス市場、治療領域別：セグメントダッシュボード
  • 治療領域別の世界の高分子バイオ分析検査サービス市場：変動分析
  • 治療領域別、2018～2030年（100万米ドル）
  • 腫瘍学
    • 腫瘍学市場推定・予測、2018～2030年
  • 感染症
    • 感染症市場推定・予測、2018～2030年
  • 心臓病
    • 心臓病市場推定・予測、2018～2030年
  • 神経学
    • 神経学市場推定・予測、2018～2030年
  • その他
    • その他市場推定・予測、2018～2030年

第8章 高分子バイオ分析検査サービス市場：最終用途別、推定・動向分析

  • 高分子バイオ分析検査サービス市場、最終用途別：セグメントダッシュボード
  • 最終用途別の世界の高分子バイオ分析検査サービス市場：変動分析
  • 最終用途別、2018～2030年（100万米ドル）
  • 中小企業
    • 中小企業市場推定・予測、2018～2030年
    • CROとCMO
    • スポンサー団体
    • その他
  • 大企業
    • 大企業市場推定・予測、2018～2030年
    • CROとCMO
    • スポンサー団体
    • その他

第9章 高分子バイオ分析検査サービス市場：地域別、推定・動向分析

  • 地域別市場シェア分析、2024年と2030年
  • 地域別市場ダッシュボード
  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • デンマーク
    • スウェーデン
    • ノルウェー
  • アジア太平洋
    • 日本
    • 中国
    • インド
    • タイ
    • 韓国
    • オーストラリア
  • ラテンアメリカ
    • ブラジル
    • アルゼンチン
    • コロンビア
  • 中東・アフリカ
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • クウェート

第10章 競合情勢

  • 市場分類
  • Market Leaders
  • Emerging Players
  • 市況分析、2024年
  • 企業プロファイル
    • Laboratory Corporation of America Holdings
    • IQVIA
    • Syneous Health
    • SGS, SA
    • WuXi AppTec
    • Intertek Plc
    • Pace Analytical Services LLC
    • ICON PLC
    • Charles River Laboratories
    • ThermoFisher Scientific
図表

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Global Large Molecule Bioanalytical Testing Services, by Phase, 2018 - 2030 (USD Million)
  • Table 4 Global Large Molecule Bioanalytical Testing Services, by Type, 2018 - 2030 (USD Million)
  • Table 5 Global Large Molecule Bioanalytical Testing Services, by Test Type, 2018 - 2030 (USD Million)
  • Table 6 Global Large Molecule Bioanalytical Testing Services, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 7 Global Large Molecule Bioanalytical Testing Services, by End Use, 2018 - 2030 (USD Million)
  • Table 8 Global Large Molecule Bioanalytical Testing Services, by Region, 2018 - 2030 (USD Million)
  • Table 9 North America Large Molecule Bioanalytical Testing Services, by Country, 2018 - 2030 (USD Million)
  • Table 10 North America Large Molecule Bioanalytical Testing Services, by Type, 2018 - 2030 (USD Million)
  • Table 11 North America Large Molecule Bioanalytical Testing Services, by Source, 2018 - 2030 (USD Million)
  • Table 12 North America Large Molecule Bioanalytical Testing Services, by Indication, 2018 - 2030 (USD Million)
  • Table 13 North America Large Molecule Bioanalytical Testing Services, by Service Type, 2018 - 2030 (USD Million)
  • Table 14 North America Large Molecule Bioanalytical Testing Services, by End Use, 2018 - 2030 (USD Million)
  • Table 15 U.S. Large Molecule Bioanalytical Testing Services, by Type, 2018 - 2030 (USD Million)
  • Table 16 U.S. Large Molecule Bioanalytical Testing Services, by Source, 2018 - 2030 (USD Million)
  • Table 17 U.S. Large Molecule Bioanalytical Testing Services, by Indication, 2018 - 2030 (USD Million)
  • Table 18 U.S. Large Molecule Bioanalytical Testing Services, by Service Type, 2018 - 2030 (USD Million)
  • Table 19 U.S. Large Molecule Bioanalytical Testing Services, by End Use, 2018 - 2030 (USD Million)
  • Table 20 Canada Large Molecule Bioanalytical Testing Services, by Type, 2018 - 2030 (USD Million)
  • Table 21 Canada Large Molecule Bioanalytical Testing Services, by Source, 2018 - 2030 (USD Million)
  • Table 22 Canada Large Molecule Bioanalytical Testing Services, by Indication, 2018 - 2030 (USD Million)
  • Table 23 Canada Large Molecule Bioanalytical Testing Services, by Service Type, 2018 - 2030 (USD Million)
  • Table 24 Canada Large Molecule Bioanalytical Testing Services, by End Use, 2018 - 2030 (USD Million)
  • Table 25 Mexico Large Molecule Bioanalytical Testing Services, by Phase, 2018 - 2030 (USD Million)
  • Table 26 Mexico Large Molecule Bioanalytical Testing Services, by Type, 2018 - 2030 (USD Million)
  • Table 27 Mexico Large Molecule Bioanalytical Testing Services, by Test Type, 2018 - 2030 (USD Million)
  • Table 28 Mexico Large Molecule Bioanalytical Testing Services, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 29 Mexico Large Molecule Bioanalytical Testing Services, by End Use, 2018 - 2030 (USD Million)
  • Table 30 Europe Large Molecule Bioanalytical Testing Services, by Country, 2018 - 2030 (USD Million)
  • Table 31 Europe Large Molecule Bioanalytical Testing Services, by Type, 2018 - 2030 (USD Million)
  • Table 32 Europe Large Molecule Bioanalytical Testing Services, by Source, 2018 - 2030 (USD Million)
  • Table 33 Europe Large Molecule Bioanalytical Testing Services, by Indication, 2018 - 2030 (USD Million)
  • Table 34 Europe Large Molecule Bioanalytical Testing Services, by Service Type, 2018 - 2030 (USD Million)
  • Table 35 Europe Large Molecule Bioanalytical Testing Services, by End Use, 2018 - 2030 (USD Million)
  • Table 36 Germany Large Molecule Bioanalytical Testing Services, by Type, 2018 - 2030 (USD Million)
  • Table 37 Germany Large Molecule Bioanalytical Testing Services, by Source, 2018 - 2030 (USD Million)
  • Table 38 Germany Large Molecule Bioanalytical Testing Services, by Indication, 2018 - 2030 (USD Million)
  • Table 39 Germany Large Molecule Bioanalytical Testing Services, by Service Type, 2018 - 2030 (USD Million)
  • Table 40 Germany Large Molecule Bioanalytical Testing Services, by End Use, 2018 - 2030 (USD Million)
  • Table 41 UK Large Molecule Bioanalytical Testing Services, by Type, 2018 - 2030 (USD Million)
  • Table 42 UK Large Molecule Bioanalytical Testing Services, by Source, 2018 - 2030 (USD Million)
  • Table 43 UK Large Molecule Bioanalytical Testing Services, by Indication, 2018 - 2030 (USD Million)
  • Table 44 UK Large Molecule Bioanalytical Testing Services, by Service Type, 2018 - 2030 (USD Million)
  • Table 45 UK Large Molecule Bioanalytical Testing Services, by End Use, 2018 - 2030 (USD Million)
  • Table 46 France Large Molecule Bioanalytical Testing Services, by Type, 2018 - 2030 (USD Million)
  • Table 47 France Large Molecule Bioanalytical Testing Services, by Source, 2018 - 2030 (USD Million)
  • Table 48 France Large Molecule Bioanalytical Testing Services, by Indication, 2018 - 2030 (USD Million)
  • Table 49 France Large Molecule Bioanalytical Testing Services, by Service Type, 2018 - 2030 (USD Million)
  • Table 50 France Large Molecule Bioanalytical Testing Services, by End Use, 2018 - 2030 (USD Million)
  • Table 51 Italy Large Molecule Bioanalytical Testing Services, by Phase, 2018 - 2030 (USD Million)
  • Table 52 Italy Large Molecule Bioanalytical Testing Services, by Type, 2018 - 2030 (USD Million)
  • Table 53 Italy Large Molecule Bioanalytical Testing Services, by Test Type, 2018 - 2030 (USD Million)
  • Table 54 Italy Large Molecule Bioanalytical Testing Services, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 55 Italy Large Molecule Bioanalytical Testing Services, by End Use, 2018 - 2030 (USD Million)
  • Table 56 Spain Large Molecule Bioanalytical Testing Services, by Phase, 2018 - 2030 (USD Million)
  • Table 57 Spain Large Molecule Bioanalytical Testing Services, by Type, 2018 - 2030 (USD Million)
  • Table 58 Spain Large Molecule Bioanalytical Testing Services, by Test Type, 2018 - 2030 (USD Million)
  • Table 59 Spain Large Molecule Bioanalytical Testing Services, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 60 Spain Large Molecule Bioanalytical Testing Services, by End Use, 2018 - 2030 (USD Million)
  • Table 61 Denmark Large Molecule Bioanalytical Testing Services, by Phase, 2018 - 2030 (USD Million)
  • Table 62 Denmark Large Molecule Bioanalytical Testing Services, by Type, 2018 - 2030 (USD Million)
  • Table 63 Denmark Large Molecule Bioanalytical Testing Services, by Test Type, 2018 - 2030 (USD Million)
  • Table 64 Denmark Large Molecule Bioanalytical Testing Services, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 65 Denmark Large Molecule Bioanalytical Testing Services, by End Use, 2018 - 2030 (USD Million)
  • Table 66 Sweden Large Molecule Bioanalytical Testing Services, by Phase, 2018 - 2030 (USD Million)
  • Table 67 Sweden Large Molecule Bioanalytical Testing Services, by Type, 2018 - 2030 (USD Million)
  • Table 68 Sweden Large Molecule Bioanalytical Testing Services, by Test Type, 2018 - 2030 (USD Million)
  • Table 69 Sweden Large Molecule Bioanalytical Testing Services, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 70 Sweden Large Molecule Bioanalytical Testing Services, by End Use, 2018 - 2030 (USD Million)
  • Table 71 Norway Large Molecule Bioanalytical Testing Services, by Phase, 2018 - 2030 (USD Million)
  • Table 72 Norway Large Molecule Bioanalytical Testing Services, by Type, 2018 - 2030 (USD Million)
  • Table 73 Norway Large Molecule Bioanalytical Testing Services, by Test Type, 2018 - 2030 (USD Million)
  • Table 74 Norway Large Molecule Bioanalytical Testing Services, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 75 Norway Large Molecule Bioanalytical Testing Services, by End Use, 2018 - 2030 (USD Million)
  • Table 76 Asia Pacific Large Molecule Bioanalytical Testing Services, by Country, 2018 - 2030 (USD Million)
  • Table 77 Asia Pacific Large Molecule Bioanalytical Testing Services, by Phase, 2018 - 2030 (USD Million)
  • Table 78 Asia Pacific Large Molecule Bioanalytical Testing Services, by Type, 2018 - 2030 (USD Million)
  • Table 79 Asia Pacific Large Molecule Bioanalytical Testing Services, by Test Type, 2018 - 2030 (USD Million)
  • Table 80 Asia Pacific Large Molecule Bioanalytical Testing Services, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 81 Asia Pacific Large Molecule Bioanalytical Testing Services, by End Use, 2018 - 2030 (USD Million)
  • Table 82 China Large Molecule Bioanalytical Testing Services, by Phase, 2018 - 2030 (USD Million)
  • Table 83 China Large Molecule Bioanalytical Testing Services, by Type, 2018 - 2030 (USD Million)
  • Table 84 China Large Molecule Bioanalytical Testing Services, by Test Type, 2018 - 2030 (USD Million)
  • Table 85 China Large Molecule Bioanalytical Testing Services, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 86 China Large Molecule Bioanalytical Testing Services, by End Use, 2018 - 2030 (USD Million)
  • Table 87 Japan Large Molecule Bioanalytical Testing Services, by Phase, 2018 - 2030 (USD Million)
  • Table 88 Japan Large Molecule Bioanalytical Testing Services, by Type, 2018 - 2030 (USD Million)
  • Table 89 Japan Large Molecule Bioanalytical Testing Services, by Test Type, 2018 - 2030 (USD Million)
  • Table 90 Japan Large Molecule Bioanalytical Testing Services, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 91 Japan Large Molecule Bioanalytical Testing Services, by End Use, 2018 - 2030 (USD Million)
  • Table 92 India Large Molecule Bioanalytical Testing Services, by Phase, 2018 - 2030 (USD Million)
  • Table 93 India Large Molecule Bioanalytical Testing Services, by Type, 2018 - 2030 (USD Million)
  • Table 94 India Large Molecule Bioanalytical Testing Services, by Test Type, 2018 - 2030 (USD Million)
  • Table 95 India Large Molecule Bioanalytical Testing Services, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 96 India Large Molecule Bioanalytical Testing Services, by End Use, 2018 - 2030 (USD Million)
  • Table 97 South Korea Large Molecule Bioanalytical Testing Services, by Phase, 2018 - 2030 (USD Million)
  • Table 98 South Korea Large Molecule Bioanalytical Testing Services, by Type, 2018 - 2030 (USD Million)
  • Table 99 South Korea Large Molecule Bioanalytical Testing Services, by Test Type, 2018 - 2030 (USD Million)
  • Table 100 South Korea Large Molecule Bioanalytical Testing Services, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 101 South Korea Large Molecule Bioanalytical Testing Services, by End Use, 2018 - 2030 (USD Million)
  • Table 102 Australia Large Molecule Bioanalytical Testing Services, by Phase, 2018 - 2030 (USD Million)
  • Table 103 Australia Large Molecule Bioanalytical Testing Services, by Type, 2018 - 2030 (USD Million)
  • Table 104 Australia Large Molecule Bioanalytical Testing Services, by Test Type, 2018 - 2030 (USD Million)
  • Table 105 Australia Large Molecule Bioanalytical Testing Services, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 106 Australia Large Molecule Bioanalytical Testing Services, by End Use, 2018 - 2030 (USD Million)
  • Table 107 Thailand Large Molecule Bioanalytical Testing Services, by Phase, 2018 - 2030 (USD Million)
  • Table 108 Thailand Large Molecule Bioanalytical Testing Services, by Type, 2018 - 2030 (USD Million)
  • Table 109 Thailand Large Molecule Bioanalytical Testing Services, by Test Type, 2018 - 2030 (USD Million)
  • Table 110 Thailand Large Molecule Bioanalytical Testing Services, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 111 Thailand Large Molecule Bioanalytical Testing Services, by End Use, 2018 - 2030 (USD Million)
  • Table 112 Latin America Large Molecule Bioanalytical Testing Services, by Country, 2018 - 2030 (USD Million)
  • Table 113 Latin America Large Molecule Bioanalytical Testing Services, by Phase, 2018 - 2030 (USD Million)
  • Table 114 Latin America Large Molecule Bioanalytical Testing Services, by Type, 2018 - 2030 (USD Million)
  • Table 115 Latin America Large Molecule Bioanalytical Testing Services, by Test Type, 2018 - 2030 (USD Million)
  • Table 116 Latin America Large Molecule Bioanalytical Testing Services, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 117 Latin America Large Molecule Bioanalytical Testing Services, by End Use, 2018 - 2030 (USD Million)
  • Table 118 Brazil Large Molecule Bioanalytical Testing Services, by Phase, 2018 - 2030 (USD Million)
  • Table 119 Brazil Large Molecule Bioanalytical Testing Services, by Type, 2018 - 2030 (USD Million)
  • Table 120 Brazil Large Molecule Bioanalytical Testing Services, by Test Type, 2018 - 2030 (USD Million)
  • Table 121 Brazil Large Molecule Bioanalytical Testing Services, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 122 Brazil Large Molecule Bioanalytical Testing Services, by End Use, 2018 - 2030 (USD Million)
  • Table 123 Argentina Large Molecule Bioanalytical Testing Services, by Phase, 2018 - 2030 (USD Million)
  • Table 124 Argentina Large Molecule Bioanalytical Testing Services, by Type, 2018 - 2030 (USD Million)
  • Table 125 Argentina Large Molecule Bioanalytical Testing Services, by Test Type, 2018 - 2030 (USD Million)
  • Table 126 Argentina Large Molecule Bioanalytical Testing Services, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 127 Argentina Large Molecule Bioanalytical Testing Services, by End Use, 2018 - 2030 (USD Million)
  • Table 128 Middle East & Africa Large Molecule Bioanalytical Testing Services, by Country, 2018 - 2030 (USD Million)
  • Table 129 Middle East & Africa Large Molecule Bioanalytical Testing Services, by Phase, 2018 - 2030 (USD Million)
  • Table 130 Middle East & Africa Large Molecule Bioanalytical Testing Services, by Type, 2018 - 2030 (USD Million)
  • Table 131 Middle East & Africa Large Molecule Bioanalytical Testing Services, by Test Type, 2018 - 2030 (USD Million)
  • Table 132 Middle East & Africa Large Molecule Bioanalytical Testing Services, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 133 Middle East & Africa Large Molecule Bioanalytical Testing Services, by End Use, 2018 - 2030 (USD Million)
  • Table 134 South Africa Large Molecule Bioanalytical Testing Services, by Phase, 2018 - 2030 (USD Million)
  • Table 135 South Africa Large Molecule Bioanalytical Testing Services, by Type, 2018 - 2030 (USD Million)
  • Table 136 South Africa Large Molecule Bioanalytical Testing Services, by Test Type, 2018 - 2030 (USD Million)
  • Table 137 South Africa Large Molecule Bioanalytical Testing Services, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 138 South Africa Large Molecule Bioanalytical Testing Services, by End Use, 2018 - 2030 (USD Million)
  • Table 139 Saudi Arabia Large Molecule Bioanalytical Testing Services, by Phase, 2018 - 2030 (USD Million)
  • Table 140 Saudi Arabia Large Molecule Bioanalytical Testing Services, by Type, 2018 - 2030 (USD Million)
  • Table 141 Saudi Arabia Large Molecule Bioanalytical Testing Services, by Test Type, 2018 - 2030 (USD Million)
  • Table 142 Saudi Arabia Large Molecule Bioanalytical Testing Services, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 143 Saudi Arabia Large Molecule Bioanalytical Testing Services, by End Use, 2018 - 2030 (USD Million)
  • Table 144 UAE Large Molecule Bioanalytical Testing Services, by Phase, 2018 - 2030 (USD Million)
  • Table 145 UAE Large Molecule Bioanalytical Testing Services, by Type, 2018 - 2030 (USD Million)
  • Table 146 UAE Large Molecule Bioanalytical Testing Services, by Test Type, 2018 - 2030 (USD Million)
  • Table 147 UAE Large Molecule Bioanalytical Testing Services, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 148 UAE Large Molecule Bioanalytical Testing Services, by End Use, 2018 - 2030 (USD Million)
  • Table 149 Kuwait Large Molecule Bioanalytical Testing Services, by Phase, 2018 - 2030 (USD Million)
  • Table 150 Kuwait Large Molecule Bioanalytical Testing Services, by Type, 2018 - 2030 (USD Million)
  • Table 151 Kuwait Large Molecule Bioanalytical Testing Services, by Test Type, 2018 - 2030 (USD Million)
  • Table 152 Kuwait Large Molecule Bioanalytical Testing Services, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 153 Kuwait Large Molecule Bioanalytical Testing Services, by End Use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Information Procurement
  • Fig. 2 Primary Research Pattern
  • Fig. 3 Market Research Approaches
  • Fig. 4 Value Chain-Based Sizing & Forecasting
  • Fig. 5 Market Formulation & Validation
  • Fig. 6 Large Molecule Bioanalytical Testing Services, Market Segmentation
  • Fig. 7 Market Driver Relevance Analysis (Current & Future Impact)
  • Fig. 8 Market Restraint Relevance Analysis (Current & Future Impact)
  • Fig. 9 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • Fig. 10 Porter's Five Forces Analysis
  • Fig. 11 Regional Marketplace: Key Takeaways
  • Fig. 12 Global Large Molecule Bioanalytical Testing Services, for Preclinical, 2018 - 2030 (USD Million)
  • Fig. 13 Global Large Molecule Bioanalytical Testing Services, for With Antibody, 2018 - 2030 (USD Million)
  • Fig. 14 Global Large Molecule Bioanalytical Testing Services, for Without Antibody (ELISA Based Assay), 2018 - 2030 (USD Million)
  • Fig. 15 Global Large Molecule Bioanalytical Testing Services, for Clinical, 2018 - 2030 (USD Million)
  • Fig. 16 Global Large Molecule Bioanalytical Testing Services, for Pharmacokinetics, 2018 - 2030 (USD Million)
  • Fig. 17 Global Large Molecule Bioanalytical Testing Services, for ADA, 2018 - 2030 (USD Million)
  • Fig. 18 Global Large Molecule Bioanalytical Testing Services, for Others, 2018 - 2030 (USD Million)
  • Fig. 19 Global Large Molecule Bioanalytical Testing Services, for ADME, 2018 - 2030 (USD Million)
  • Fig. 20 Global Large Molecule Bioanalytical Testing Services, for PD, 2018 - 2030 (USD Million)
  • Fig. 21 Global Large Molecule Bioanalytical Testing Services, for Bioavailability, 2018 - 2030 (USD Million)
  • Fig. 22 Global Large Molecule Bioanalytical Testing Services, for Bioequivalence , 2018 - 2030 (USD Million)
  • Fig. 23 Global Large Molecule Bioanalytical Testing Services, for Other Tests, 2018 - 2030 (USD Million)
  • Fig. 24 Global Large Molecule Bioanalytical Testing Services, for Oncology, 2018 - 2030 (USD Million)
  • Fig. 25 Global Large Molecule Bioanalytical Testing Services, for Infectious Diseases, 2018 - 2030 (USD Million)
  • Fig. 26 Global Large Molecule Bioanalytical Testing Services, for Cardiology, 2018 - 2030 (USD Million)
  • Fig. 27 Global Large Molecule Bioanalytical Testing Services, for Neurology, 2018 - 2030 (USD Million)
  • Fig. 28 Global Large Molecule Bioanalytical Testing Services, for Others, 2018 - 2030 (USD Million)
  • Fig. 29 Global Large Molecule Bioanalytical Testing Services, for SMEs, 2018 - 2030 (USD Million)
  • Fig. 30 Global Large Molecule Bioanalytical Testing Services, for CROs & CMOs, 2018 - 2030 (USD Million)
  • Fig. 31 Global Large Molecule Bioanalytical Testing Services, for Sponsor Organizations, 2018 - 2030 (USD Million)
  • Fig. 32 Global Large Molecule Bioanalytical Testing Services, for Others, 2018 - 2030 (USD Million)
  • Fig. 33 Global Large Molecule Bioanalytical Testing Services, for Large Firms, 2018 - 2030 (USD Million)
  • Fig. 34 Global Large Molecule Bioanalytical Testing Services, for CROs & CMOs, 2018 - 2030 (USD Million)
  • Fig. 35 Global Large Molecule Bioanalytical Testing Services, for Sponsor Organizations, 2018 - 2030 (USD Million)
  • Fig. 36 Global Large Molecule Bioanalytical Testing Services, for Others, 2018 - 2030 (USD Million)
  • Fig. 37 Regional Outlook, 2024 & 2030
  • Fig. 38 North America Large Molecule Bioanalytical Testing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 U.S. Large Molecule Bioanalytical Testing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 Canada Large Molecule Bioanalytical Testing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 Mexico Large Molecule Bioanalytical Testing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 Europe Large Molecule Bioanalytical Testing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 UK Large Molecule Bioanalytical Testing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 Germany Large Molecule Bioanalytical Testing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 France Large Molecule Bioanalytical Testing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 Italy Large Molecule Bioanalytical Testing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Spain Large Molecule Bioanalytical Testing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 Denmark Large Molecule Bioanalytical Testing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Sweden Large Molecule Bioanalytical Testing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 Norway Large Molecule Bioanalytical Testing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Asia Pacific Large Molecule Bioanalytical Testing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 India Large Molecule Bioanalytical Testing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 China Large Molecule Bioanalytical Testing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 Japan Large Molecule Bioanalytical Testing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 South Korea Large Molecule Bioanalytical Testing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 Australia Large Molecule Bioanalytical Testing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 Thailand Large Molecule Bioanalytical Testing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 Latin America Large Molecule Bioanalytical Testing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 59 Brazil Large Molecule Bioanalytical Testing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 60 Argentina Large Molecule Bioanalytical Testing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 61 Colombia Large Molecule Bioanalytical Testing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 62 Middle East & Africa Large Molecule Bioanalytical Testing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 63 South Africa Large Molecule Bioanalytical Testing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 64 Saudi Arabia Large Molecule Bioanalytical Testing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 65 UAE Large Molecule Bioanalytical Testing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 66 Kuwait Large Molecule Bioanalytical Testing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
目次
Product Code: GVR-4-68038-979-1

Large Molecule Bioanalytical Testing Services Market Growth & Trends:

The global large molecule bioanalytical testing services market size is expected to reach USD 3.70 billion by 2030, registering a CAGR of 9.63% from 2025 to 2030, according to a new report by Grand View Research, Inc. The increased use of bioanalytical testing in clinical trials of biomarkers, large molecules, and other substances is the main driver of the industry. The rising incidence of chronic diseases and the rising demand for clinical trials in developing nations are the factors driving the market growth. For instance, according to the WHO, around 10 million people died from cancer in 2020. As per the estimates of cancer, 30.2 million people are likely to have cancer by 2040. Other factors that are anticipated to drive the segment growth include a rise in biologics, high demand for advanced technologies, and the need for personalized orphan drugs & medicines.

It is also projected that factors like technological advancement, globalization of clinical trials, and the rising need for CROs to perform clinical trials will accelerate industry expansion. Large pharmaceutical and bioanalytical firms, however, encountered difficulties as a result of the COVID-19 pandemic, which hampered clinical studies and treatments. Along with the workload of the COVID-19 project, which involves starting clinical trials, preclinical testing, doing bioanalysis, and interacting with regulatory bodies, other difficulties include the loss of workers at sites. The non-Covid initiatives were delayed, and there were lengthy 4-6 month wait times as a result of the resources being used to support the bioanalytical, preclinical, and clinical testing for the Covid trials. They must also resolve assays that are related to Covid and those that are not.

Large Molecule Bioanalytical Testing Services Market Report Highlights:

  • The clinical phase segment dominated the market in 2024 with the largest revenue share of 66.6%. The growing prevalence of chronic diseases and increasing demand for clinical trials in developing countries are factors expected to drive segment growth.
  • The global market is segmented into pharmacokinetics, Antidrug Antibodies (ADA), and others. The ADA segment accounted for the largest revenue share of the global market in 2024.
  • The bioavailability segment held the largest revenue share in 2024. The segment growth can be attributed to the high demand for these services in generic drug manufacturing.
  • Oncology accounted for a majority of revenue share in the global market in 2024. The segment is also anticipated to register the fastest CAGR during the forecast period.
  • The SMEs segment dominated the global market in 2024. The segment is also anticipated to grow at the fastest CAGR over the forecast timeline, retaining its market dominance.
  • North America large molecule bioanalytical testing services market dominated globally in 2024 with a revenue share of more than 48.94%.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Phase
    • 1.1.2. Type
    • 1.1.3. Test Type
    • 1.1.4. Therapeutic Area
    • 1.1.5. End Use
    • 1.1.6. Regional scope
    • 1.1.7. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
    • 1.6.1. Commodity flow analysis (Model 1)
      • 1.6.1.1. Approach 1: Commodity flow approach
    • 1.6.2. Volume price analysis (Model 2)
      • 1.6.2.1. Approach 2: Volume price analysis
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Large Molecule Bioanalytical Testing Services Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Technological advancements in analytical testing
      • 3.2.1.2. Regulatory control and increasing awareness regarding bioanalytical testing
      • 3.2.1.3. Growing R&D expenditure in the pharmaceutical and biopharmaceutical industries
      • 3.2.1.4. Rising demand for outsourcing of analytical testing
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Compliance issues while outsourcing
      • 3.2.2.2. Data security concerns
  • 3.3. R&D Investments & Funding Perspective
  • 3.4. Clinical Trials Volume Analysis, (2023)
  • 3.5. Pricing Model Analysis
  • 3.6. Technology Landscape
  • 3.7. Large Molecule Bioanalytical Testing Services Market Analysis Tools
    • 3.7.1. Porter's Five Forces Analysis
    • 3.7.2. PESTEL Analysis

Chapter 4. Large Molecule Bioanalytical Testing Services Market: Phase Estimates & Trend Analysis

  • 4.1. Large Molecule Bioanalytical Testing Services Market, By Phase: Segment Dashboard
  • 4.2. Global Large Molecule Bioanalytical Testing Services Market by Phase: Movement Analysis
  • 4.3. Global Large Molecule Bioanalytical Testing Services Market Estimates & Forecasts, By Phase, 2018 - 2030 (USD Million) for the following
  • 4.4. Preclinical
    • 4.4.1. Preclinical market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.4.2. With Antibody
      • 4.4.2.1. With Antibody market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.4.3. Without Antibody (ELISA Based Assay)
      • 4.4.3.1. Without Antibody (ELISA Based Assay) market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.5. Clinical
    • 4.5.1. Clinical market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. Large Molecule Bioanalytical Testing Services Market by Type Estimates & Trend Analysis

  • 5.1. Large Molecule Bioanalytical Testing Services Market, By Type: Segment Dashboard
  • 5.2. Global Large Molecule Bioanalytical Testing Services Market by Type: Movement Analysis
  • 5.3. Global Large Molecule Bioanalytical Testing Services Market Estimates & Forecasts, By Type, 2018 - 2030 (USD Million) for the following
  • 5.4. Pharmacokinetics
    • 5.4.1. Pharmacokinetics market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.5. ADA
    • 5.5.1. ADA market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.6. Others
    • 5.6.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 6. Large Molecule Bioanalytical Testing Services Market: Test Type Estimates & Trend Analysis

  • 6.1. Large Molecule Bioanalytical Testing Services Market, By Test: Segment Dashboard
  • 6.2. Global Large Molecule Bioanalytical Testing Services Market by Test Type: Movement Analysis
  • 6.3. Global Large Molecule Bioanalytical Testing Services Market Estimates & Forecasts, By Test Type, 2018 - 2030 (USD Million) for the following
  • 6.4. ADME
    • 6.4.1. ADME market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.5. PD
    • 6.5.1. PD market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.6. Bioavailability
    • 6.6.1. Bioavailability market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.7. Bioequivalence
    • 6.7.1. Bioequivalence market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.8. Other Tests
    • 6.8.1. Other tests market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 7. Large Molecule Bioanalytical Testing Services Market by Therapeutic Area Estimates & Trend Analysis

  • 7.1. Large Molecule Bioanalytical Testing Services Market, By Therapeutic Area: Segment Dashboard
  • 7.2. Global Large Molecule Bioanalytical Testing Services Market by Therapeutic Area: Movement Analysis
  • 7.3. Global Large Molecule Bioanalytical Testing Services Market Estimates & Forecasts, By Therapeutic Area, 2018 - 2030 (USD Million) for the following
  • 7.4. Oncology
    • 7.4.1. Oncology market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.5. Infectious Diseases
    • 7.5.1. Infectious Diseases market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.6. Cardiology
    • 7.6.1. Cardiology market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.7. Neurology
    • 7.7.1. Neurology market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.8. Others
    • 7.8.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 8. Large Molecule Bioanalytical Testing Services Market by End Use Estimates & Trend Analysis

  • 8.1. Large Molecule Bioanalytical Testing Services Market, By End Use: Segment Dashboard
  • 8.2. Global Large Molecule Bioanalytical Testing Services Market by End Use: Movement Analysis
  • 8.3. Global Large Molecule Bioanalytical Testing Services Market Estimates & Forecasts, By End Use, 2018 - 2030 (USD Million) for the following
  • 8.4. SMEs
    • 8.4.1. SMEs market estimates and forecasts, 2018 to 2030 (USD Million)
    • 8.4.2. CROs & CMOs
      • 8.4.2.1. CROs & CMOs market estimates and forecasts, 2018 to 2030 (USD Million)
    • 8.4.3. Sponsor Organizations
      • 8.4.3.1. Sponsor Organizations market estimates and forecasts, 2018 to 2030 (USD Million)
    • 8.4.4. Others
      • 8.4.4.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
  • 8.5. Large Firms
    • 8.5.1. Large Firms market estimates and forecasts, 2018 to 2030 (USD Million)
    • 8.5.2. CROs & CMOs
      • 8.5.2.1. CROs & CMOs market estimates and forecasts, 2018 to 2030 (USD Million)
    • 8.5.3. Sponsor Organizations
      • 8.5.3.1. Sponsor Organizations market estimates and forecasts, 2018 to 2030 (USD Million)
    • 8.5.4. Others
      • 8.5.4.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 9. Large Molecule Bioanalytical Testing Services Market: Regional Estimates & Trend Analysis

  • 9.1. Regional market share analysis, 2024 & 2030
  • 9.2. Regional Market Dashboard
  • 9.3. North America
    • 9.3.1. MEA market estimates and forecast, 2018 - 2030 (USD Million)
    • 9.3.2. U.S.
      • 9.3.2.1. Key Country Dynamics
      • 9.3.2.2. Competitive Scenario
      • 9.3.2.3. Regulatory Framework
      • 9.3.2.4. U.S. large molecule bioanalytical testing services market estimates and forecast, 2018 - 2030 (USD Million)
    • 9.3.3. Canada
      • 9.3.3.1. Key Country Dynamics
      • 9.3.3.2. Competitive Scenario
      • 9.3.3.3. Regulatory Framework
      • 9.3.3.4. Canada large molecule bioanalytical testing services market estimates and forecast, 2018 - 2030 (USD Million)
    • 9.3.4. Mexico
      • 9.3.4.1. Key Country Dynamics
      • 9.3.4.2. Competitive Scenario
      • 9.3.4.3. Regulatory Framework
      • 9.3.4.4. Mexico large molecule bioanalytical testing services market estimates and forecast, 2018 - 2030 (USD Million)
  • 9.4. Europe
    • 9.4.1. Europe market estimates and forecast, 2018 - 2030 (USD Million)
    • 9.4.2. UK
      • 9.4.2.1. Key Country Dynamics
      • 9.4.2.2. Competitive Scenario
      • 9.4.2.3. Regulatory Framework
      • 9.4.2.4. UK large molecule bioanalytical testing services market estimates and forecast, 2018 - 2030 (USD Million)
    • 9.4.3. Germany
      • 9.4.3.1. Key Country Dynamics
      • 9.4.3.2. Competitive Scenario
      • 9.4.3.3. Regulatory Framework
      • 9.4.3.4. Germany large molecule bioanalytical testing services market estimates and forecast, 2018 - 2030 (USD Million)
    • 9.4.4. France
      • 9.4.4.1. Key Country Dynamics
      • 9.4.4.2. Competitive Scenario
      • 9.4.4.3. Regulatory Framework
      • 9.4.4.4. France large molecule bioanalytical testing services market estimates and forecast, 2018 - 2030 (USD Million)
    • 9.4.5. Italy
      • 9.4.5.1. Key Country Dynamics
      • 9.4.5.2. Competitive Scenario
      • 9.4.5.3. Regulatory Framework
      • 9.4.5.4. Italy large molecule bioanalytical testing services market estimates and forecast, 2018 - 2030 (USD Million)
    • 9.4.6. Spain
      • 9.4.6.1. Key Country Dynamics
      • 9.4.6.2. Competitive Scenario
      • 9.4.6.3. Regulatory Framework
      • 9.4.6.4. Spain large molecule bioanalytical testing services market estimates and forecast, 2018 - 2030 (USD Million)
    • 9.4.7. Denmark
      • 9.4.7.1. Key Country Dynamics
      • 9.4.7.2. Competitive Scenario
      • 9.4.7.3. Regulatory Framework
      • 9.4.7.4. Denmark large molecule bioanalytical testing services market estimates and forecast, 2018 - 2030 (USD Million)
    • 9.4.8. Sweden
      • 9.4.8.1. Key Country Dynamics
      • 9.4.8.2. Competitive Scenario
      • 9.4.8.3. Regulatory Framework
      • 9.4.8.4. Sweden large molecule bioanalytical testing services market estimates and forecast, 2018 - 2030 (USD Million)
    • 9.4.9. Norway
      • 9.4.9.1. Key Country Dynamics
      • 9.4.9.2. Competitive Scenario
      • 9.4.9.3. Regulatory Framework
      • 9.4.9.4. Norway large molecule bioanalytical testing services market estimates and forecast, 2018 - 2030 (USD Million)
  • 9.5. Asia Pacific
    • 9.5.1. Asia Pacific market estimates and forecast, 2018 - 2030 (USD Million)
    • 9.5.2. Japan
      • 9.5.2.1. Key Country Dynamics
      • 9.5.2.2. Competitive Scenario
      • 9.5.2.3. Regulatory Framework
      • 9.5.2.4. Japan large molecule bioanalytical testing services market estimates and forecast, 2018 - 2030 (USD Million)
    • 9.5.3. China
      • 9.5.3.1. Key Country Dynamics
      • 9.5.3.2. Competitive Scenario
      • 9.5.3.3. Regulatory Framework
      • 9.5.3.4. China large molecule bioanalytical testing services market estimates and forecast, 2018 - 2030 (USD Million)
    • 9.5.4. India
      • 9.5.4.1. Key Country Dynamics
      • 9.5.4.2. Competitive Scenario
      • 9.5.4.3. Regulatory Framework
      • 9.5.4.4. India large molecule bioanalytical testing services market estimates and forecast, 2018 - 2030 (USD Million)
    • 9.5.5. Thailand
      • 9.5.5.1. Key Country Dynamics
      • 9.5.5.2. Competitive Scenario
      • 9.5.5.3. Regulatory Framework
      • 9.5.5.4. Thailand large molecule bioanalytical testing services market estimates and forecast, 2018 - 2030 (USD Million)
    • 9.5.6. South Korea
      • 9.5.6.1. Key Country Dynamics
      • 9.5.6.2. Competitive Scenario
      • 9.5.6.3. Regulatory Framework
      • 9.5.6.4. South Korea large molecule bioanalytical testing services market estimates and forecast, 2018 - 2030 (USD Million)
    • 9.5.7. Australia
      • 9.5.7.1. Key Country Dynamics
      • 9.5.7.2. Competitive Scenario
      • 9.5.7.3. Regulatory Framework
      • 9.5.7.4. Australia large molecule bioanalytical testing services market estimates and forecast, 2018 - 2030 (USD Million)
  • 9.6. Latin America
    • 9.6.1. Latin America market estimates and forecast, 2018 - 2030 (USD Million)
    • 9.6.2. Brazil
      • 9.6.2.1. Key Country Dynamics
      • 9.6.2.2. Competitive Scenario
      • 9.6.2.3. Regulatory Framework
      • 9.6.2.4. Brazil large molecule bioanalytical testing services market estimates and forecast, 2018 - 2030 (USD Million)
    • 9.6.3. Argentina
      • 9.6.3.1. Key Country Dynamics
      • 9.6.3.2. Competitive Scenario
      • 9.6.3.3. Regulatory Framework
      • 9.6.3.4. Argentina large molecule bioanalytical testing services market estimates and forecast, 2018 - 2030 (USD Million)
    • 9.6.4. Colombia
      • 9.6.4.1. Key Country Dynamics
      • 9.6.4.2. Competitive Scenario
      • 9.6.4.3. Regulatory Framework
      • 9.6.4.4. Colombia large molecule bioanalytical testing services market estimates and forecast, 2018 - 2030 (USD Million)
  • 9.7. MEA
    • 9.7.1. MEA market estimates and forecast, 2018 - 2030 (USD Million)
    • 9.7.2. South Africa
      • 9.7.2.1. Key Country Dynamics
      • 9.7.2.2. Competitive Scenario
      • 9.7.2.3. Regulatory Framework
      • 9.7.2.4. South Africa large molecule bioanalytical testing services market estimates and forecast, 2018 - 2030 (USD Million)
    • 9.7.3. Saudi Arabia
      • 9.7.3.1. Key Country Dynamics
      • 9.7.3.2. Competitive Scenario
      • 9.7.3.3. Regulatory Framework
      • 9.7.3.4. Saudi Arabia large molecule bioanalytical testing services market estimates and forecast, 2018 - 2030 (USD Million)
    • 9.7.4. UAE
      • 9.7.4.1. Key Country Dynamics
      • 9.7.4.2. Competitive Scenario
      • 9.7.4.3. Regulatory Framework
      • 9.7.4.4. UAE large molecule bioanalytical testing services market estimates and forecast, 2018 - 2030 (USD Million)
    • 9.7.5. Kuwait
      • 9.7.5.1. Key Country Dynamics
      • 9.7.5.2. Competitive Scenario
      • 9.7.5.3. Regulatory Framework
      • 9.7.5.4. Kuwait large molecule bioanalytical testing services market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 10. Competitive Landscape

  • 10.1. Market Categorization
  • 10.2. Market Leaders
  • 10.3. Emerging Players
  • 10.4. Market Position Analysis, 2024
  • 10.5. Company Profiles
    • 10.5.1. Laboratory Corporation of America Holdings
      • 10.5.1.1. Company overview
      • 10.5.1.2. Financial Performance
      • 10.5.1.3. Service benchmarking
      • 10.5.1.4. Strategic initiatives
    • 10.5.2. IQVIA
      • 10.5.2.1. Company overview
      • 10.5.2.2. Financial performance
      • 10.5.2.3. Service benchmarking
      • 10.5.2.4. Strategic initiatives
    • 10.5.3. Syneous Health
      • 10.5.3.1. Company overview
      • 10.5.3.2. Financial performance
      • 10.5.3.3. Service benchmarking
      • 10.5.3.4. Strategic initiatives
    • 10.5.4. SGS, SA
      • 10.5.4.1. Company overview
      • 10.5.4.2. Financial performance
      • 10.5.4.3. Service benchmarking
      • 10.5.4.4. Strategic initiatives
    • 10.5.5. WuXi AppTec
      • 10.5.5.1. Company overview
      • 10.5.5.2. Financial performance
      • 10.5.5.3. Service benchmarking
      • 10.5.5.4. Strategic initiatives
    • 10.5.6. Intertek Plc
      • 10.5.6.1. Company overview
      • 10.5.6.2. Financial performance
      • 10.5.6.3. Service benchmarking
      • 10.5.6.4. Strategic initiatives
    • 10.5.7. Pace Analytical Services LLC
      • 10.5.7.1. Company overview
      • 10.5.7.2. Financial performance
      • 10.5.7.3. Service benchmarking
      • 10.5.7.4. Strategic initiatives
    • 10.5.8. ICON PLC
      • 10.5.8.1. Company overview
      • 10.5.8.2. Financial performance
      • 10.5.8.3. Service benchmarking
      • 10.5.8.4. Strategic initiatives
    • 10.5.9. Charles River Laboratories
      • 10.5.9.1. Company overview
      • 10.5.9.2. Financial performance
      • 10.5.9.3. Service benchmarking
      • 10.5.9.4. Strategic initiatives
    • 10.5.10. ThermoFisher Scientific
      • 10.5.10.1. Company overview
      • 10.5.10.2. Financial performance
      • 10.5.10.3. Service benchmarking
      • 10.5.10.4. Strategic initiatives